Ijraset Journal For Research in Applied Science and Engineering Technology
Authors: Rutuja Arjun Bagade, Sundaram Yashwant Salunkhe , Kajal Sanjay Edake, Bhau Eknath Shendage, Pruthviraj Hanumant Tarade
DOI Link: https://doi.org/10.22214/ijraset.2024.59728
Certificate: View Certificate
Through out history and across the plant kingdom has a provided a variety of medicines. The evaluation and spread of antibiotic resistance as well as the evaluation of new strains of disease causing agents ,is of great concern to the global health community .plants with the antimicrobial activity are also known to the numerous ,yet prior to a decade ago,minimal research had been conducted in the area of antifungal and antibiotic activities of the medicinal plants .our ability to the effectively that disease is dependent on the development sources of novel drugs is traditional medicines nature has been a source of a medicines agent of thousands of year and impressive number modern drug has been isolated from nature resources traditional medicines is an important source of potentially useful area source of great economic value all over the world .plants with antimicrobial activity are also known to the numerous yet prior to a decade ago, minimal research had been conducted in the area of antifungal medicinal plants this review focus major method used to asses in vitro testing antifungal and antibacterial agents of medicinal plants .
I. INTRODUCTION
Over three-quarters of the world population relies mainly on plants and plant extracts for health care more than 30% of the entire plant species at one time or other were used for medicinal purpose .It is a estimated that world market for plant derived drug may account for about Rs.2,00,000 crores.
Indian contribution is less than Rs.2000 crores.Indian export of raw drug has steadily grown at 26% to Rs.165 crores in 1994-95 from Rs 130 crores in 1991-92.The annual production of medicinal and aromatic plants raw material is worth about Rs .200 crores .This is likely to touch US billion 1150 by the year 2000 and US 55 Trillion by 2050 (Thomas and Skaria 19880. It has been estimated that in developed counties such as united states plants drug constituted as much 25% of the total drugs while in fast developing countries such as china and india ,the contribution is as much as 80% .Thus the economic importance of medicinal plants is much more to countries such as Indian than to rest of the world. These countries such as india provide two third of the plants used in modern system of medicine and the heath care system of rural population depends on indigenous system of medicine. Traditional sytem of medicine continoue to be widely practiced on many accounts population rise in adequate supply of drugs .
Prohibitive cost of treatments side effects of several allopathic drugs and developments of resistance to currently used drug for Infectious disease have led to increased emphasis on the use of plant materials as a sources of medicines .
Antibiotics are one of our most of important weapons in fighting bacterial infectious and have greatly benefied the health releted quality of human life sencce their introduction . However ,over the past few decades ,these health benefits are under threat as many commonly used Antibiotics have become less and less effective against certain illness not, only because many of them produced toxic resistancet bacteria . It is essential to investigate newer drug with lesser resistance.Drug derived for natural sources play a significant role in the prevention and treatment of the human diseases. In many developing countries traditional medicine is one of the primary health care system (Farnsworth,1993: Houghton 1995).Herbs are widely exploited in the traditional medicine and their curative potentials are well documented (Dubeyet al.,1995) About 61% of new drugs developed between 1980 and 2002 were the based on natural product and they have been very successfully specially in the areas of Infectious disease and cancer (Cragget al. 2005).
Recent trends , however show that the discovery rate of active novel chemical entieties descaling (Lam 2007 ). Natural product of higher plants may give new soures of the Antimicribial agents with possibly novel mechanism of action (Shahidi,2004).The effect of plant extracts on bacterial have been studied by a very large number of researches is different parts of the world ( Reddy.2001).Plants are rich in a wide variety of a secondary metabolites such as tannins ,terpenoids ,alkaloid, flavonoids, glycosides etc .which have been found in vitro to have anti microbial properties (Danhanukaret al..2000).Herbal medicines have been known to man for countrie .therapeutic efficacy of the many indigeneous plants for several disorders has been decribed by practionrs of the traditional medicines (Ramasamy and Charles 2009).
Antimicrobial properties of medicinal plants are being increasingly reported from dirrerent parts of the world. The world health Organization estimation that plants extracts or their active constituents are used as falk medicines in traditional therapies of 80% of worlds populations.
II. MECHANISM
A. Efflux Pump
Throughout the mechanism of the efflux pump (EP) the antibacterial agent is pumped out faster than the time it requires to be diffused in bacterial cells and consequently, the intrabacterial concentration becomes much lower than the effective value. By reducing the intrabacterial concentration of EP-mediated inhibitors of protein synthesis systems such as ribosomes, bacterial protein synthesis procedures are often performed without interruption . Antibiotic resistance via the mechanism of EPs can be observed in a wide range of pathogenic Gram-positive and Gram- negative bacteria and fungi such as Staphylococcus aureus, Pseudomonas aeruginosa, Acinetobacter baumannii and Candida albicans
B. Structural modification of porins
Antibiotics influx is mainly controlled by porins which are proteins able to form water-filled open channels that allowing the passive transportation of molecules across lipid bilayer membranes Variation in porin structure results in alteration of membrane permeability and is a mechanism to escape from the antibacterial agents . This type of antibacterial resistance is frequently found in Gram-negative pathogens such as Acinetobacter spp. and Pseudomonas spp.
C. Enzymetic inactivation
Resistance to aminoglycosides in Gram-negative bacteria is most often mediated through the modification of functional groups by utilizing three kinds of modifying enzymes. These modified products have displayed a considerably lower affinity for RNA and have caused the blockage of protein synthesis since they are not capable of binding to ribosomes
D. Alteration of target sites
Drug-binding site alteration can be counted as another resistance mechanism, in which the antibacterial agent is not able to react with the targeted bacterial site and thus results in a dramatic reduction in the antibacterial activity of the agent
III. MEDICINAL PLANT
1.Acridine 2.Quinilizines 3.Betalianes
APPLICATIONS
Our data express 1)plant extract have great potentialas antimicrobial compounds against microorganisms .thus they can be used in the treatment of infectious disease caused by resistant microbes .the synergistic effect from the aasociation of antibiotic with plants extract against resistant bacteria leads to new choice for the treatment of infectious disease .this effect enables the use of the respective antibiotic when it is no longer effective by itself during therapeutic treatment.
[1] Singh A.K et al, Anti microbial and Anti helminthic activity of hantaki,journal of research in Ayurveda and Siddha,Vol ,XXII,No_3-4:208-215. [2] Anonymous ,Ayurvedic Pharmacopia of India ,New Dehli.Published by ministry of Health and family welfare ,Govt,of India ,part _1,Vol-1:47 [3] Bhaumik T ,et al, Chemical investigation of terminalia chebula Retz_,Bulletin of Medico Ethino- botinical Rsearch ,1989;10: 190-192. [4] Anonymous ,database of Medicnal plants used in Ayurveda ,New Dehli, published by central council for research in Ayurvedic sciences (CCRAS)2 ,2008, Vol-iii: 282. [5] Dahanukar SA. Et al, Cyto protective effect of terminalia chehula and Asparagus racesosus on gastric mucosa , India Drugs , 1983;20 : 442 -445 [6] Cruz MC, Santos PO, Barbosa Jr AM, de Mélo DL, Alviano CS, Antoniolli AR, Alviano DS, Trindade RC. Antifungal activity of Brazilian medicinal plants involved in popular treatment of mycoses. J Ethnopharmacol. 2007 May 4;111(2):409–412. [PubMed] [Google Scholar] [7] Ruberto G, Baratta MT, Deans SG, Dorman HJ. Antioxidant and antimicrobial activity of Foeniculum vulgare and Crithmum maritimum essential oils. Planta Med. 2000 Dec;66(8):687– 693. [PubMed] [Google Scholar) [8] Paterson DL. Impact of antibiotic resistance in gram-negative bacilli on empirical and definitive antibiotic therapy. Clin Infect Dis. 2008 Sep 15;47(Suppl 1):S14–S20. doi: 10.1086/590062. [PubMed] [CrossRef] [Google Scholar] [9] Cheesbrough M. Medical Laboratory Manual for Tropical Countries. Oxford, United Kingdom: Oxford, Publishers; 1984. Microscopic examination of specimens; pp. 32–33. [Google Scholar] [10] Peirano G. Multi resistant enterobacteriaceae new threat to an old prob; expect review of anti infective therapy. Expert Rev Anti Infect Ther. 2008;6:657–669. [PubMed] [Google Scholar] [11] Eggleston K, Zhang R, Zeckhauser RJ. The global challenge of antimicrobial resistance: insights from economic analysis. Int J Environ Res Public Health. 2010 Aug;7(8):3141–3149. doi: 10.3390/ijerph7083141. [PMC free article] [PubMed] [CrossRef] [Google Scholar] [12] Bibi Y, Nisa S, Chaudhary FM, Zia M. Antibacterial activity of some selected medicinal plants of Pakistan. BMC Complement Altern Med. 2011 Jun 30;11:52. doi: 10.1186/1472-6882-11-52. [PMC free article] [PubMed] [CrossRef] [Google Scholar] [13] Hussain T, Arshad M, Khan S, Sattar H, Qureshi MS. In vitro screening of methanol plant extracts for their antibacterial activity. Pak J Bot. 2011;43(1):531–538. [Google Scholar] [14] Kirby WM, Yoshihara GM, Sundsted KS, Warren JH. Clinical usefulness of a single disc method for antibiotic sensitivity testing. Antibiot Annu. 1956-1957:892–897. [PubMed] [Google Scholar] [15] Islam M, Azhar I, Usmanghani K, Ahmad A, Shahbuddin Evaluation of antibacterial activity of Bergenia ciliate. Pak J Pharm Sci. 2002;15:21–27. [PubMed] [Google Scholar] [16] Ertürk Ö. Antibacterial and antifungal effects of alcoholic extracts of 41 medicinal plants growing in Turkey. Czech J Food Sci. 2010;28:53–60. [Google Scholar] [17] Kumar MG, Jeyraaj IA, Jeyaraaj R, Loganathan P. Antimicrobial activity of aqueous extract of leaf and stem extract of Santalum album. Anc Sci Life. 2006 Jan;25(3-4):6–9. [PMC free article] [PubMed] [Google Scholar] Arakawa, Tsutomu; Yamasaki, Hisashi; Ikeda, Keiko; Ejima, Daisuke; Naito, Takeshi; Koyama, A. Hajime (2009). \"Antiviral and Virucidal Activities of Natural Products\". Current Medicinal Chemistry. 16 (20): 2485–2497. doi:10.2174/092986709788682065. PMID 19601794. [18] ^ Lampejo, Temi (July 2020). \"Influenza and antiviral resistance: an overview\". European Journal of Clinical Microbiology & Infectious Diseases. 39 (7): 1201–1208. doi:10.1007/s10096-020-03840-9. ISSN 0934-9723. PMC 7223162. PMID 32056049. [19] ^ Pink, Richard; Hudson, Alan; Mouriès, Marie-Annick; Bendig, Mary (September 2005). \"Opportunities and Challenges in Antiparasitic Drug Discovery\". Nature Reviews Drug Discovery. 4 (9): 727–740. doi:10.1038/nrd1824. ISSN 1474-1784. PMID 16138106. S2CID 19379800. [20] ^ Firth, Anton; Prathapan, Praveen (2021-01-01). \"Broad-spectrum therapeutics: A new antimicrobialass\". Current Research in Pharmacology and Drug Discovery. 2:100011. doi:10.1016/j.crphar.2020.100011. ISSN 2590-2571. PMC 8035643. PMID 34870144. [21] Castillo, A.; Lucia, L.M.; Roberson, D.B.; Stevenson, T.H.; Mercado, I.; Acuff, G.R. (January 2001). \"Lactic Acid Sprays Reduce Bacterial Pathogens on Cold Beef Carcass Surfaces and in Subsequently Produced Ground Beef\". Journal of Food Protection. 64 (1): 58–62. doi:10.4315/0362- 028X-64.1.58. PMID 11198442. [22] ^ Ratia, Carlos; Soengas, Raquel G.; Soto, Sara M. (2022). \"Gold-Derived Molecules as NAntimicrobial Agents\". Frontiers in Microbiology. 13: 846959. doi:10.3389/fmicb.2022.846959. ISSN 1664-302X. PMC 8984462. PMID 35401486. [23] ^ Pintus, Anna; Aragoni, M. Carla; Cinellu, Maria A.; Maiore, Laura; Isaia, Francesco; Lippolis, Vito; Orrù, Germano; Tuveri, Enrica; Zucca, Antonio; Arca, Massimiliano (May 2017). \"[Au(pyb-H)(mnt)]: A novel gold(III) 1,2-dithiolene cyclometalated complex with antimicrobial activity (pyb-H=C-deprotonated 2- benzylpyridine; mnt=1,2-dicyanoethene-1,2-dithiolate)\". Journal of Inorganic Biochemistry. 170: 188–194. doi:10.1016/j.jinorgbio.2017.02.015. ISSN 1873-3344. PMID 28260677. [24] ^ Marques, Fernanda; Sousa, Sílvia A.; Leitão, Jorge H.; Morais, Tânia S.; Le Gal, Yann; Lorcy, Dominique (2021-04-01). \"Gold(III) bisdithiolate complexes: molecular conductors that also exhibit anticancer and antimicrobial activities\". Annals of Medicine. 53 (sup1): S29–S30. doi:10.1080/07853890.2021.1896913. ISSN 0785-3890. PMC 8480714.
Copyright © 2024 Rutuja Arjun Bagade, Sundaram Yashwant Salunkhe , Kajal Sanjay Edake, Bhau Eknath Shendage, Pruthviraj Hanumant Tarade. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Paper Id : IJRASET59728
Publish Date : 2024-04-01
ISSN : 2321-9653
Publisher Name : IJRASET
DOI Link : Click Here